InspireMD- Warrants Receivables

The latest receivables for NSPRZ is $2.6M as of December 2025. That compares with $2.3M in the prior-year period — up 13.9% year over year. Investors often review this figure alongside InspireMD- Warrants's historical trend and sector peers before judging valuation or financial health.

Over the past year, NSPRZ's receivables moved from $2.3M to $2.6M — a 13.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InspireMD- Warrants's operating scale or balance-sheet position.

A receivables figure of $2.6M for NSPRZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NSPRZ's receivables ($2.6M), review year-over-year change from $2.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack InspireMD- Warrants's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.